Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is an alkylating antineoplastic drug. It works by forming cross-links with DNA to prevent cancer cell division. It is used to treat lymphoma, leukemia, and some autoimmune diseases.

Question 2

When and how should this medicine be taken?

Accepted Answer

• Take on empty stomach • Take with plenty of water • Increase fluid intake during therapy

Question 3

When should this medicine not be used?

Accepted Answer

• Do not use during pregnancy • Do not use if you have severe bladder problems • Do not use if you have low blood cell counts

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Use carefully in patients with diabetes, weak immune system, or heart problems • May cause bladder problems • Not recommended during breastfeeding • Regular blood tests needed

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Not safe during pregnancy; • May cause fetal harm; • Avoid use

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Use carefully in patients with diabetes, weak immune system, or heart problems • May cause bladder problems • Not recommended during breastfeeding • Regular blood tests needed

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • For once-daily dosing: If you remember on the same day, take the dose. • For twice-daily dosing: If more than 6 hours until your next dose, take the missed dose. • Take your next dose at the regular time. • If you're unsure, contact your doctor or pharmacist.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Overdose symptoms: Bone marrow suppression, hemorrhagic cystitis. • Treatment: MESNA, hydration, G-CSF.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Hair loss, nausea, skin changes, bladder problems, infertility • What to do: Stay hydrated; Regular blood tests; Report blood in urine; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What medical indications are treated with Cyclophosphamide?

Accepted Answer

Cyclophosphamide (Disease-Modifying Antirheumatic Drugs (DMARDs)) is a pharmaceutical active substance. It is indicated for the treatment of Adenocarcinoma of the Ovary, Breast Carcinoma, Burkitt's Lymphoma, Histiocytic Lymphoma, Hodgkin's Disease, Leukemia, Lymphocytic Lymphoma, Malignant Lymphoma, Mixed-Cell Type Lymphoma, Multiple Myeloma, Mycosis Fungoides, Neuroblastoma, Retinoblastoma.

Question 11

What is the recommended dosage for Cyclophosphamide?

Accepted Answer

Standard adult dosage: Intravenous – 40-50 mg/kg. Pediatric dosage: Intravenous – 40-50 mg/kg (400-1800 mg/m²). Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 12

Is Cyclophosphamide safe during pregnancy and breastfeeding?

Accepted Answer

Cyclophosphamide is classified under Pregnancy Category "Not Assigned". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 13

What are the common side effects of Cyclophosphamide?

Accepted Answer

Alopecia; skin and nails hyperpigmentation; nausea and vomiting; mucositis; inappropriate antidiuretic hormone secretion; carbohydrate metabolism disturbances; gonadal suppression; interstitial pulmonary fibrosis; **Pote

Clinical Information	Administration Information
Indication: Malignant Diseases Age: Adult Condition: Initial course	Dose: Intravenous – 40-50 mg/kg Duration: divided over 2-5 days Note: Adjust dosage based on specific regimen administered, response to treatment, myelosuppression or other adverse reactions, and patient risk factors.
Indication: Malignant Diseases Age: Adult	Dose: Intravenous – 10-15 mg/kg Frequency: every 7-10 days Note: Adjust dosage based on specific regimen administered, response to treatment, myelosuppression or other adverse reactions, and patient risk factors.

Clinical Information	Administration Information
Indication: Malignant Diseases Condition: Intermittent therapy	Dose: Intravenous – 40-50 mg/kg (400-1800 mg/m²) Duration: divided over 2-5 days Note: may be repeated at intervals of 2-4 weeks
Indication: Malignant Diseases Condition: Continuous daily therapy	Dose: Intravenous – 60-120 mg/m²/day (1-2.5 mg/kg/day) Frequency: daily

Drug Name	Risk Factors
Protease inhibitors	May increase incidence of mucositis
Doxorubicin, other cardiotoxic drugs	Increased risk of cardiotoxicity

Disease Name	Risk Factors
Bladder Hemorrhage	Risk of severe bleeding
Bone-marrow Aplasia	Risk of severe infection

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Renal Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources